XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Shareholders Equity (Tables)
9 Months Ended
Sep. 30, 2024
Shareholders Equity  
Schedule Of Shareholders' Equity

(in thousands, except

 

 

 

 

 

 

 

 

 

 

Share amounts)

 

Common

 

 

Common

 

 

Additional

 

 

 

 

Total

 

 

 

Stock

 

 

Stock

 

 

Paid-in

 

 

Accumulated

 

 

Shareholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2023

 

 

79,586,358

 

 

$796

 

 

$82,796

 

 

$(57,642)

 

$25,950

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

59

 

 

 

-

 

 

 

59

 

Issuance of shares- option exercises

 

 

50,000

 

 

 

-

 

 

 

14

 

 

 

-

 

 

 

14

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(730)

 

 

(730)

Balance at March 31, 2024

 

 

79,636,358

 

 

$796

 

 

$82,869

 

 

$(58,372)

 

$25,293

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

356

 

 

 

-

 

 

 

356

 

Issuance of shares for cash - ATM

 

 

1,802,060

 

 

 

18

 

 

 

1,200

 

 

 

-

 

 

 

1,218

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(762)

 

 

(762)

Balance at June 30, 2024

 

 

81,438,418

 

 

$814

 

 

$84,425

 

 

$(59,134)

 

$26,105

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

125

 

 

 

-

 

 

 

125

 

Issuance of shares- option exercises

 

 

200,000

 

 

 

2

 

 

 

38

 

 

 

-

 

 

 

40

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,276)

 

 

(2,276)

Balance at September 30, 2024

 

 

81,638,418

 

 

$816

 

 

$84,588

 

 

$(61,410)

 

$23,994

 

(in thousands, except

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share amounts)

 

Common

 

 

Common

 

 

Additional

 

 

 

 

 

Total

 

 

 

Stock

 

 

Stock

 

 

Paid-in

 

 

Accumulated

 

 

Shareholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2022

 

 

64,801,373

 

 

$648

 

 

$74,886

 

 

$(53,888)

 

$21,646

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

67

 

 

 

-

 

 

 

67

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(380)

 

 

(380)

Balance at March 31, 2023

 

 

64,801,373

 

 

$648

 

 

$74,953

 

 

$(54,268)

 

$21,333

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

59

 

 

 

-

 

 

 

59

 

Issuance of shares - option exercises

 

 

50,000

 

 

 

1

 

 

 

13

 

 

 

-

 

 

 

14

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,040)

 

 

(1,040)

Balance at June 30, 2023

 

 

64,851,373

 

 

$649

 

 

$75,025

 

 

$(55,308)

 

$20,366

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

58

 

 

 

-

 

 

 

58

 

Issuance of shares - option exercises

 

 

145,000

 

 

 

1

 

 

 

44

 

 

 

-

 

 

 

45

 

Private placement

 

 

4,166,667

 

 

 

42

 

 

 

2,380

 

 

 

 

 

 

 

2,422

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,292)

 

 

(1,292)

Balance at September 30, 2023

 

 

69,163,040

 

 

$692

 

 

$77,507

 

 

$(56,600)

 

$21,599